Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study-Reference-Cited by-同舟云学术

Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study

Published:2021-01 Issue:1 Volume:109 Page:120-130
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Li Wang-Zhong,Lv Shu-Hui,Liu Guo-Ying,Liang Hu,Guo Xiang,Lv Xing,Liu Kui-Yuan,Qiang Meng-Yun,Chen Xi,Gu Sophie Z.,Xie Chang-Qing,Xia Wei-Xiong,Xiang Yan-Qun

Funder

Guangdong Medical Research Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference45 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement;Lee;Oral Oncol,2012

3. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy;Pan;Cancer,2016

4. Nasopharyngeal carcinoma;Chen;Lancet,2019

5. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type;Fandi;J Clin Oncol,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma;npj Precision Oncology;2024-05-16

2. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma;BMC Cancer;2024-05-11

3. Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy;Scientific Reports;2024-02-17

4. Loco‐regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real‐world retrospective study from two cancer centers;Head & Neck;2024-02-05

5. Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma;Oral Oncology;2023-12